RBC Capital raised the firm’s price target on American Healthcare REIT (AHR) to $30 from $28 and keeps an Outperform rating on the shares, updating the firm’s model after the company’s Q3 FFO beat. The company is well positioned to deliver solid organic growth and capitalize on the strong seniors housing and healthy skilled nursing facility backdrops, the analyst tells investors in a research note. RBC adds that while it is still being conservative with its new investment expectations, American Healthcare REIT is now better positioned to pursue accretive investments.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $36 from $31 at BofA
- American Healthcare REIT price target raised to $29 from $27 at Truist
- American Healthcare REIT, Inc. Reports Q3 2024 Results
- American Healthcare REIT Reports Q3 2024 Financial Results
- American Healthcare REIT raises FY24 NFFO to $1.40-$1.43 from $1.23-$1.27